On Wednesday, Fitterfly, a digital health and therapeutics, announced to raise fund $12 million in Series A, which was led by Amazon Smbhav Venture Fund and Fireside Ventures. Existing investors also included named 9 Unicorns, Venture Catalysts and Nihar Parikh, who is the Founder of Health Ventures, and Sriram Natarajan who is the Founder of Molbio.

To increase Diabefly’s reach, their digital therapeutics and clinically proven programme. Also, to prevent and manage reverse diabetes. This fund is also used to enhance the technology stack to give unique clinical insights to FitterFly

• Kotak Mahindra Bank Shares Crash 13% Post RBI Action 
• Nestle India Joins Hands With Dr Reddy for Nutritional Health Solutions 
• Inox Wind Shares Traded 9% Higher On Board Proposal For Bonus Shares Issuance
• Nestle India Stocks Gained 3% on Q4FY24 Business and Financial Updates
• Rail Vikas Nigam Shares Gain 3% on Securing Project Worth Rs 239 Crore 

Dr Arbinder Singal, CEO and co-founder, of Fitterfly, said, “We want to take our clinically-proven diabetes and weight management system to the people who need it the most. This funding will help us strengthen our research, launch new verticals in the heart health space and grow our customer base by reaching out to people living with diabetes and the universe of doctors and organisations in the field of chronic disease management. Our corporate wellness models push the envelope from ‘tick-mark-based bundling’ to an ‘outcome-based approach’.”